Enhancing natural killer cell function with gp41-targeting bispecific antibodies to combat HIV infection

Conclusion: On the basis of their in-vitro killing efficacy, bsAbs may provide a promising strategy to improve NK-mediated immune targeting of infected cells during HIV infection.
Source: AIDS - Category: Infectious Diseases Tags: BASIC SCIENCE Source Type: research